Variant report

Variant	nsv1057410
Chromosome Location	chr17:20736492-20782474
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:742)
CpG islands
(count:1161)
Chromatin interactive
region (count:10)
LncRNA
region (count:7)
Mature miRNA
region (count: 0)
miRNA target
sites (count:1)

(count:742 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr17:20779608-20779761	K562	blood:	n/a	n/a
2	ARID3A	chr17:20771647-20772028	HepG2	liver:	n/a	n/a
3	ARID3A	chr17:20776349-20776886	K562	blood:	n/a	n/a
4	ARID3A	chr17:20781779-20781972	K562	blood:	n/a	n/a
5	ARID3A	chr17:20774749-20774943	K562	blood:	n/a	n/a
6	ATF1	chr17:20769945-20769997	K562	blood:	n/a	n/a
7	ATF1	chr17:20771215-20771847	K562	blood:	n/a	n/a
8	BCL11A	chr17:20775300-20775548	GM12878	blood:	n/a	n/a
9	BCLAF1	chr17:20776283-20777496	K562	blood:	n/a	chr17:20777209-20777218 chr17:20777479-20777488
10	BCLAF1	chr17:20771699-20774204	K562	blood:	n/a	n/a
11	BCLAF1	chr17:20775471-20776280	K562	blood:	n/a	chr17:20775770-20775779
12	BCLAF1	chr17:20781762-20782706	K562	blood:	n/a	chr17:20781993-20782002
13	BCLAF1	chr17:20780371-20781449	K562	blood:	n/a	n/a
14	BCLAF1	chr17:20774457-20775131	K562	blood:	n/a	n/a
15	BCLAF1	chr17:20778589-20779013	K562	blood:	n/a	n/a
16	BHLHE40	chr17:20774735-20774939	K562	blood:	n/a	n/a
17	BHLHE40	chr17:20771808-20772010	K562	blood:	n/a	n/a
18	BHLHE40	chr17:20771094-20771527	K562	blood:	n/a	n/a
19	CBX3	chr17:20771289-20772187	K562	blood:	n/a	n/a
20	CCNT2	chr17:20771695-20772039	K562	blood:	n/a	n/a
21	CEBPB	chr17:20771375-20771995	K562	blood:	n/a	n/a
22	CEBPB	chr17:20778359-20778698	K562	blood:	n/a	n/a
23	CEBPB	chr17:20776332-20776660	K562	blood:	n/a	chr17:20776488-20776499
24	CEBPB	chr17:20775328-20775517	K562	blood:	n/a	n/a
25	CEBPB	chr17:20752281-20752447	A549	lung:	n/a	n/a
26	CEBPB	chr17:20776343-20776814	K562	blood:	n/a	chr17:20776488-20776499
27	CEBPD	chr17:20776400-20776848	K562	blood:	n/a	n/a
28	CEBPD	chr17:20776604-20777370	K562	blood:	n/a	n/a
29	CEBPD	chr17:20771666-20772111	K562	blood:	n/a	n/a
30	CEBPD	chr17:20771738-20772231	K562	blood:	n/a	n/a
31	CHD1	chr17:20773198-20774195	H1-hESC	embryonic stem cell:	n/a	n/a
32	CHD1	chr17:20771782-20772757	H1-hESC	embryonic stem cell:	n/a	n/a
33	CHD2	chr17:20776965-20777765	K562	blood:	n/a	n/a
34	CHD2	chr17:20776536-20776736	K562	blood:	n/a	n/a
35	CHD2	chr17:20771438-20771981	H1-hESC	embryonic stem cell:	n/a	n/a
36	CHD2	chr17:20771264-20772113	K562	blood:	n/a	n/a
37	CHD2	chr17:20771296-20771487	HepG2	liver:	n/a	n/a
38	CHD2	chr17:20755762-20755953	H1-hESC	embryonic stem cell:	n/a	n/a
39	CHD2	chr17:20782430-20782645	K562	blood:	n/a	n/a
40	CTCF	chr17:20752154-20752548	A549	lung:	n/a	chr17:20752345-20752363 chr17:20752340-20752361
41	CTCF	chr17:20752040-20752190	HAc	cerebellar:	n/a	n/a
42	CTCF	chr17:20752360-20752510	AG04449	skin:	n/a	n/a
43	CTCF	chr17:20756100-20756250	MCF-7	breast:	n/a	n/a
44	CTCF	chr17:20752380-20752530	BE2_C	brain:	n/a	n/a
45	CTCF	chr17:20753338-20753408	Lung_OC	lung:	n/a	n/a
46	CTCF	chr17:20755860-20756010	Caco-2	colon:	n/a	n/a
47	CTCF	chr17:20752300-20752450	SAEC	small airway:	n/a	chr17:20752345-20752363 chr17:20752340-20752361
48	CTCF	chr17:20752340-20752490	GM12866	blood:	n/a	chr17:20752345-20752363 chr17:20752340-20752361
49	CTCF	chr17:20755960-20756110	A549	lung:	n/a	n/a
50	CTCF	chr17:20752294-20752400	A549	lung:	n/a	chr17:20752345-20752363 chr17:20752340-20752361

(count:1161 , 50 per page) page: 1 2 3 4 5 6 7 ... 24

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:20751508-20751558	SK-N-MC	brain:	n/a
2	chr17:20747314-20747364	MCF-7	breast:	n/a
3	chr17:20751508-20751558	SK-N-MC	brain:	n/a
4	chr17:20747314-20747364	MCF-7	breast:	n/a
5	chr17:20755949-20755999	HCT-116	colon:	n/a
6	chr17:20745278-20745328	HepG2	liver:	n/a
7	chr17:20747199-20747249	SK-N-MC	brain:	n/a
8	chr17:20755949-20755999	SK-N-SH	brain:	n/a
9	chr17:20744547-20744597	HL-60	blood:	n/a
10	chr17:20755949-20755999	HRPEpiC	eye:	n/a
11	chr17:20744682-20744732	GM12878	blood:	n/a
12	chr17:20756214-20756264	NHBE	bronchial:	n/a
13	chr17:20755508-20755558	NB4	blood:	n/a
14	chr17:20771879-20771929	HAEpiC	amniotic membrane:	n/a
15	chr17:20770315-20770365	PrEC	prostate:	n/a
16	chr17:20747199-20747249	HCT-116	colon:	n/a
17	chr17:20747199-20747249	ovcar-3	ovarian:	n/a
18	chr17:20755949-20755999	IMR90	lung:	fetal
19	chr17:20747314-20747364	ProgFib	skin:	n/a
20	chr17:20770315-20770365	HPAEpiC	pulmonary alveolar:	n/a
21	chr17:20747073-20747123	NHDF-neo	bronchial:	n/a
22	chr17:20744547-20744597	NH-A	brain:	n/a
23	chr17:20771377-20771427	SAEC	small airway:	n/a
24	chr17:20744547-20744597	HepG2	liver:	n/a
25	chr17:20747314-20747364	A549	lung:	n/a
26	chr17:20756214-20756264	GM19239	blood:	n/a
27	chr17:20756118-20756168	HCF	heart:	n/a
28	chr17:20755508-20755558	ECC-1	luminal epithelium:	n/a
29	chr17:20747058-20747108	GM12892	blood:	n/a
30	chr17:20771377-20771427	Caco-2	colon:	n/a
31	chr17:20771551-20771601	GM19239	blood:	n/a
32	chr17:20771377-20771427	HUVEC	blood vessel:	n/a
33	chr17:20755508-20755558	ProgFib	skin:	n/a
34	chr17:20744547-20744597	RPTEC	kidney:	n/a
35	chr17:20747199-20747249	PrEC	prostate:	n/a
36	chr17:20771551-20771601	ECC-1	luminal epithelium:	n/a
37	chr17:20755268-20755318	H1-hESC	embryonic stem cell:	embryo
38	chr17:20755268-20755318	HAEpiC	amniotic membrane:	n/a
39	chr17:20747058-20747108	HCT-116	colon:	n/a
40	chr17:20744547-20744597	ECC-1	luminal epithelium:	n/a
41	chr17:20747058-20747108	HCF	heart:	n/a
42	chr17:20747073-20747123	SK-N-MC	brain:	n/a
43	chr17:20755268-20755318	Jurkat	blood:	n/a
44	chr17:20755949-20755999	HEEpiC	esophagus:	n/a
45	chr17:20751508-20751558	AG10803	skin:	n/a
46	chr17:20771879-20771929	T-47D	breast:	n/a
47	chr17:20756214-20756264	PFSK-1	brain:	n/a
48	chr17:20751508-20751558	NH-A	brain:	n/a
49	chr17:20747058-20747108	NB4	blood:	n/a
50	chr17:20744682-20744732	HAEpiC	amniotic membrane:	n/a

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr17:20776529..20779374-chr17:21510196..21511711,2	K562	blood:
2	chr17:20774807..20776983-chr17:20818893..20820623,2	K562	blood:
3	chr17:20769754..20771503-chr17:25415743..25417258,2	K562	blood:
4	chr17:20780706..20782458-chr17:20785204..20786797,2	K562	blood:
5	chr17:20778622..20781617-chr17:20784685..20786554,2	K562	blood:
6	chr17:20776859..20779023-chr17:21114293..21116494,2	K562	blood:
7	chr17:20774798..20778610-chr17:20778817..20781618,3	K562	blood:
8	chr17:20773460..20776251-chr4:34006664..34009123,2	K562	blood:
9	chr17:20774798..20778610-chr17:20778817..20781618,3	K562	blood:
10	chr17:20766270..20770547-chr17:21518548..21521594,4	K562	blood:

(count:7 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DHRS7B-5	chr17:20771860-20771998	ENSG00000233098.3
2	lnc-DHRS7B-9	chr17:20761000-20763371	NONHSAT146841
3	lnc-DHRS7B-5	chr17:20771856-20771998	ENSG00000233098.3
4	lnc-DHRS7B-6	chr17:20759259-20760630	ENSG00000266369.1
5	lnc-DHRS7B-5	chr17:20771818-20771998	ENSG00000233098.3
6	lnc-DHRS7B-8	chr17:20782018-20783423	ucscGeneNc_uc002gyj_2
7	lnc-DHRS7B-5	chr17:20771810-20771998	ENSG00000233098.3

No data

(count:1 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location	mirBase accession
1	CCDC144NL	hsa-miR-425-5p	chr17:20766875-20766897

Variant related genes	Relation type
CCDC144NL	TF binding region
ENSG00000233098	TF binding region
ENSG00000266369	TF binding region
CCDC144NL	CpG island
ENSG00000233098	CpG island
ENSG00000266369	CpG island

Extended variants
information (count: 2311 )
Associated
traits (count: 152 )

Variant overlapped rSNPs/rCNVs (count:2311 , 50 per page) page: 1 2 3 4 5 6 7 ... 47

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs564414191	chr17:20741034-20741035	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs201444042	chr17:20741061-20741062	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs532703012	chr17:20741062-20741063	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs573686096	chr17:20741063-20741064	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs77687484	chr17:20741076-20741077	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs201911096	chr17:20741077-20741078	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs16962868	chr17:20741111-20741112	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs146999269	chr17:20741144-20741145	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs114075023	chr17:20741183-20741184	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs112740068	chr17:20741206-20741207	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs187328571	chr17:20741222-20741223	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs137923826	chr17:20741279-20741280	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs2993361	chr17:20741295-20741296	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs563688024	chr17:20741301-20741302	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs191845727	chr17:20741333-20741334	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs79689005	chr17:20741334-20741335	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs551518943	chr17:20741394-20741395	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs1999866	chr17:20741402-20741403	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs1999865	chr17:20741403-20741404	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs3936950	chr17:20741410-20741411	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs537194820	chr17:20741444-20741445	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs183750452	chr17:20741452-20741453	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs1999864	chr17:20741520-20741521	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs2958459	chr17:20741578-20741579	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs532848304	chr17:20741653-20741654	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs2993360	chr17:20741660-20741661	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs569801050	chr17:20741714-20741715	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs188177429	chr17:20741806-20741807	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs190134657	chr17:20741847-20741848	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs567191390	chr17:20741875-20741876	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs534717450	chr17:20741888-20741889	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs555579717	chr17:20741943-20741944	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs553043843	chr17:20741962-20741963	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs578055034	chr17:20742021-20742022	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs538794700	chr17:20742049-20742050	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs182502584	chr17:20742114-20742115	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs372895216	chr17:20742133-20742134	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs575936955	chr17:20742166-20742167	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs377101501	chr17:20742168-20742169	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs543226800	chr17:20742290-20742291	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs561583091	chr17:20742350-20742351	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs568192522	chr17:20742474-20742475	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs573532104	chr17:20742478-20742479	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs541031535	chr17:20742571-20742572	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs1815568	chr17:20742620-20742621	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs541326367	chr17:20742622-20742623	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs570576937	chr17:20742654-20742655	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs529035391	chr17:20742662-20742663	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs186823838	chr17:20742663-20742664	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs557517312	chr17:20742671-20742672	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:152)

Disease	PMID	Source
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21509527	CNVD
Breast cancer	17142309	CNVD
Breast cancer	22522925	CNVD
Autism	20808228	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:507 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:20741000-20741800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
2	chr17:20741800-20743400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
3	chr17:20743400-20743600	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
4	chr17:20743600-20743800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
5	chr17:20743600-20744000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
6	chr17:20743600-20744800	Active TSS	Primary hematopoietic stem cells	blood
7	chr17:20743800-20744000	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
8	chr17:20743800-20744000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
9	chr17:20743800-20744600	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
10	chr17:20743800-20744600	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
11	chr17:20743800-20745200	Active TSS	Colon Smooth Muscle	Colon
12	chr17:20744000-20744400	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
13	chr17:20744000-20744400	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
14	chr17:20744000-20744400	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin01	Skin
15	chr17:20744000-20744400	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
16	chr17:20744000-20744400	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
17	chr17:20744000-20744600	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
18	chr17:20744000-20744600	Bivalent/Poised TSS	Brain Hippocampus Middle	brain
19	chr17:20744200-20744600	Bivalent Enhancer	Psoas Muscle	Psoas
20	chr17:20744400-20744600	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
21	chr17:20744400-20744600	Flanking Bivalent TSS/Enh	Cortex derived primary cultured neurospheres	brain
22	chr17:20744400-20744600	Bivalent/Poised TSS	Ganglion Eminence derived primary cultured neurospheres	brain
23	chr17:20744400-20744600	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
24	chr17:20744400-20744600	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
25	chr17:20744400-20744600	Flanking Bivalent TSS/Enh	Primary mononuclear cells fromperipheralblood	Blood
26	chr17:20744400-20744600	Bivalent Enhancer	Adipose Nuclei	Adipose
27	chr17:20744400-20744600	Bivalent Enhancer	Fetal Brain Male	brain
28	chr17:20744400-20744600	Flanking Bivalent TSS/Enh	Fetal Brain Female	brain
29	chr17:20744400-20744600	Bivalent Enhancer	Fetal Stomach	stomach
30	chr17:20744400-20744800	Enhancers	Primary B cells from peripheral blood	blood
31	chr17:20744400-20744800	Bivalent/Poised TSS	Primary T helper cells PMA-I stimulated	--
32	chr17:20744400-20744800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
33	chr17:20744400-20744800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
34	chr17:20744400-20744800	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
35	chr17:20744400-20744800	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin03	Skin
36	chr17:20744400-20744800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
37	chr17:20744400-20744800	Bivalent Enhancer	Left Ventricle	heart
38	chr17:20744400-20744800	Bivalent Enhancer	Ovary	ovary
39	chr17:20744400-20744800	Enhancers	Pancreas	Pancrea
40	chr17:20744400-20744800	Bivalent/Poised TSS	Rectal Smooth Muscle	rectum
41	chr17:20744400-20744800	Flanking Bivalent TSS/Enh	Monocytes-CD14+_RO01746	blood
42	chr17:20744400-20745200	Active TSS	Brain Inferior Temporal Lobe	brain
43	chr17:20744600-20744800	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
44	chr17:20744600-20744800	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin02	Skin
45	chr17:20744600-20744800	Bivalent/Poised TSS	Adipose Nuclei	Adipose
46	chr17:20744600-20744800	Bivalent Enhancer	Brain Hippocampus Middle	brain
47	chr17:20744600-20744800	Bivalent/Poised TSS	Skeletal Muscle Female	skeletal muscle
48	chr17:20744600-20745000	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
49	chr17:20744600-20745000	Flanking Active TSS	Primary Natural Killer cells fromperipheralblood	blood
50	chr17:20744600-20745400	Enhancers	Spleen	Spleen

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links